Biotech Cash Runway: Funding Before the Next Milestone

Can the company fund its next verified milestone?

A cash balance divided by historical burn is a starting estimate. It does not establish when a company must raise money, the terms of that financing, or whether a trial will succeed. Build a dated worksheet, then compare funding scenarios with the milestone's original evidence.

Substantially revised October 12, 2026. This revision removes unsupported risk thresholds, dilution percentages and automatic-monitoring claims. The primary materials below were checked on that date. They explain financial disclosures; they do not establish any company's current cash or trial schedule.

Collect the evidence before calculating

The SEC's Form 10-Q, Part I Items 1–2 identifies the financial statements and management's discussion and analysis (MD&A). Keep the filing link, reporting period, currency and units beside each input. A filing date and its balance-sheet date are different anchors.

Use this worksheet to make assumptions reviewable:

Input	Record beside the amount	Unresolved question
Usable liquidity	Cash, investment and restriction notes; balance-sheet date	Have any balances been counted twice or assumed available without evidence?
Operating cash use	Statement heading, covered period and sign	Is the amount cumulative or for one quarter?
Additional cash requirements	Capital spending, debt terms and dated disclosures	What is outside the chosen operating-burn estimate?
Financing	Original closing or issuance disclosure; proceeds and costs	Has cash arrived, or is it only possible future funding?
Next milestone	Trial identifier and dated registry or company disclosure	Is the date estimated, actual, or missing?

These are research questions, not assertions that every filing supplies every answer. Missing inputs stay UNKNOWN.

Distinguish operating burn from net loss and financing

The SEC's financial-statement guide separates operating, investing and financing cash flows. Net income or loss is reconciled to operating cash flows through non-cash items and changes in operating assets and liabilities. Selling shares or borrowing can add financing cash without reducing operating cash use.

Record the chosen liquidity definition rather than adding every line containing “cash” or “investments.” Check restrictions and overlapping totals in the notes. Reconcile later financing separately; do not count it both in a reported balance and again as a new inflow.

Use the right period for burn

Interim cash-flow statements can present cumulative periods; Regulation S-X Rule 10-01(c)(3) describes the period from the preceding fiscal-year end to the most recent fiscal-quarter end. Read the actual heading before treating an amount as quarterly burn.

For a hypothetical company reporting $80 million of operating cash used over nine months and $55 million over six months, the third-quarter difference is $25 million. This subtraction assumes the same fiscal year, units, sign convention and accounting basis. If those do not match, reconcile the difference before using it.

For positive operating cash use:

Runway in months = chosen usable liquidity / assumed monthly cash use

If operating cash use is zero or negative, this burn-based calculation is not applicable. It does not prove unlimited funding.

Make scenarios explicit

Assume hypothetical usable liquidity of $115 million, no additional inflows and the following constant quarterly operating cash use:

Assumed quarterly cash use	Calculation	Estimated runway
$20 million	115 / (20 / 3)	17.25 months
$25 million	115 / (25 / 3)	13.8 months
$30 million	115 / (30 / 3)	11.5 months

These calculations exclude additional capital spending and debt repayments. Add them to a dated cash-flow scenario where evidence supports them. Do not silently subtract a payment from liquidity and also include it in projected burn.

If a milestone is assumed to occur in 18 months, these scenarios suggest a funding gap worth investigating. They do not establish a financing deadline, dilution percentage or investment decision. Contingent milestones, unused offering capacity and uncommitted borrowing belong in separate scenarios, rather than being treated as cash already received.

Compare management guidance with your worksheet

The SEC's guide to reading a 10-K, Item 7 explains where management discusses liquidity, capital resources and material uncertainties. Preserve management's exact dated runway statement separately from your calculation. A difference is a question to resolve using spending assumptions, restrictions, obligations and subsequent disclosures.

For the clinical milestone, distinguish a registry's estimated completion date from a company's readout guidance. Our ClinicalTrials.gov guide explains why those dates are not interchangeable. If the relevant protocol or current disclosure is unavailable, retain UNKNOWN.

Apply the worksheet to a company

Choose a company in this page's research entry. The existing valuation-assumptions task asks about cash, debt, development stage, costs and timing, with dated primary citations and explicit unknowns. Keep this worksheet beside the answer and check whether each input refers to the same company and period. You review the company and task before running it.

The article provides a framework. A source link, a completed response, or a runway estimate alone does not prove the company can fund its next milestone.